These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9432384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
    Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, Lee JK, Kim SJ.
    Int J Tuberc Lung Dis; 2007 May; 11(5):571-6. PubMed ID: 17439684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB, Sepkowitz KA, Stoeckle M, Friedman CR, Hafner A, Riley LW.
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 8. National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
    Ti T, Lwin T, Mar TT, Maung W, Noe P, Htun A, Kluge HH, Wright A, Aziz MA, Paramasivan CN.
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
    Sanders M, Van Deun A, Ntakirutimana D, Masabo JP, Rukundo J, Rigouts L, Fissette K, Portaelst F.
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
    [Abstract] [Full Text] [Related]

  • 12. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A, Aguiman L, Adlawan S, Baring E, Quirante O, Suchi M, Endo S, Fujiki A, Mori T.
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug-resistant tuberculosis in Yangon, Myanmar.
    Phyu S, Lwin T, Ti T, Maung W, Mar WW, Shein SS, Grewal HM.
    Scand J Infect Dis; 2005 Dec; 37(11-12):846-51. PubMed ID: 16308219
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thai drug-resistant tuberculosis predictive scores.
    Boonsarngsuk V, Tansirichaiya K, Kiatboonsri S.
    Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
    [Abstract] [Full Text] [Related]

  • 20. [Drug resistance of Mycobacterium tuberculosis in a nationwide epidemiological survey in China in the year of 2000].
    Liu Y, Jiang G, Zhao L, Fu Y, Li Y, Bi Z, Wang S.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Apr; 25(4):224-7. PubMed ID: 12133331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.